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Summary
Background: Aiming to define the profile of curative atrial fibrillation (AF) ablation in Brazil, the Brazilian Cardiac 
Arrhythmia Society [Sociedade Brasileira de Arritmias Cardíacas] (SOBRAC) created the Brazilian Registry of AF Ablation 
[Registro Brasileiro de Ablação da FA].
Objective: To describe the results of this registry.  
Methods: A questionnaire was sent to SOBRAC members asking about data on patients submitted to AF ablation between 
September 2005 and November, 2006.
Results: A total of 29 groups from 13 states completed the forms. Of these, 22 (76%) had performed AF ablations. 
Between 1998 and 2001, 7 groups (32%) initiated AF ablations and between 2002 and 2006, 15 groups began to perform 
them (68%). From 1998 to 2006, 2,374 patients were submitted to ablation, 755 (32%) of them during the registry period. 
Most (70%) were males and 89% presented with paroxysmal or persistent AF. Ancillary imaging methods (intracardiac 
echocardiography and electroanatomic mapping) were used by 9 groups (41%). During an average five-month follow-
up period, total success was 82% and success without use of antiarrhythmic agents was 57%. Nevertheless, 35% of the 
patients required two or more procedures. There were 111 complications (14.7%) and 2 deaths (0.26%).
Conclusion: Curative AF ablation has been increasing significantly in our country, with success rates comparable to 
international indexes, but often more than one procedure is necessary. Despite promising results, AF ablation still 
results in significant morbidity. Supplementary imaging methods have been used more and more in an effort to increase 
efficacy and safety of the procedure. These findings should be considered by public and private funding agencies. (Arq 
Bras Cardiol 2007;88(5):258-262)
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Introduction
Atrial fibrillation (AF) is the most frequent sustained 
cardiac arrhythmia in clinical practice. Epidemiological 
data show that AF is associated with expressive morbidity 
and mortality, leading to high medical and hospital costs1. 
The disappointment generated by the modest impact of 
antiarrhythmic drugs in the natural history of AF motivated 
the development of non-drug methods seeking curative 
treatment of this arrhythmia. In this context, over the last 
decade, catheter ablation with percutaneous techniques 
evolved considerably, and has been established as a treatment 
option in selected patients with AF2. Currently, several different 
approaches are used for curative AF ablation3-16. The most 
important of these have the objective of electrical isolation of 
pulmonary veins in regard to the left atrium3-11, associated or 
not with modifications of the atrial substrate by the creation of 
linear lesions in the left atrium,10,16 elimination of fragmented 
potentials12 and AF nests,13 or the ablation of parasympathetic 
ganglia.14,15 Additionally, auxiliary imaging techniques such as 
intracardiac echocardiography and electroanatomic mapping 
have been progressively more incorporated with the goal 
of increasing the efficiency and safety of the method8,17. 
Despite the approach and technique used, when performed 
by experienced operators, AF ablation has proved to be a 
safe method with very satisfactory results2-15. Nevertheless, 
it is important to point out that AF ablation is a complex 
procedure not without risks. Several serious complications 
have been reported including cerebrovascular accidents, 
stenosis of pulmonary veins, and atrioesophageal fistulae18,19. 
These aspects of the efficacy and safety of AF ablation are 
relevant for the clinical indication of the procedure. 
In spite of the growing use of curative AF ablation, data 
on the use of these techniques in our area are scarce20-24. 
Because of the complexity of these procedures, it is important 
to identify sites, techniques used, and the results of AF ablation 
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in our country. With the goal of obtaining this information, 
the Brazilian Cardiac Arrhythmia Society (SOBRAC) created 
the Brazilian Registry of AF Ablation intending to outline the 
profile of curative AF ablation in Brazil. This article describes 
the results of this survey.
Methods
The Brazilian Registry of Atrial Fibrillation Ablation was 
entirely organized and implanted by SOBRAC. In September 
2006, a standardized questionnaire was sent to all the 692 
registered members of SOBRAC by electronic mail, inquiring 
about the principal data on patients submitted to AF ablation. 
The questionnaire was comprised of 20 questions covering the 
following specific aspects: experience of the group; indications 
and clinical characteristics of the patients submitted to AF 
ablation; pre- and post-procedure tests; ablation techniques 
and catheters used; anticoagulation regimes, and the use of 
post-ablation antiarrhythmic drugs; and, finally, results and 
complications of the procedure. 
With the aim of encouraging compliance with the 
registry, two more electronic messages were sent, ten and 
twenty days after the first communication, besides periodic 
telephone contacts. Only one form was requested per 
group of electrophysiologists because it did not need to be 
completed by all members of the team. Since the registry 
will be periodically updated, special emphasis was given 
to the results of the previous twelve months. The invitation 
to participate in the registry underlined that it is owned by 
SOBRAC and would be used exclusively by this entity. It also 
stated that all participating groups would receive credit for the 
project and that no individual results of any patient or team 
would be divulged, under any circumstance. As an additional 
guarantee of confidentiality, in this paper all information 
that could directly or indirectly lead to identification of the 
institutions was omitted. The forms were to be returned to 
SOBRAC preferably by electronic mail by the November 20, 
2006 deadline. Data were then analyzed, compiled, and 
posteriorly stored by the registry committee of SOBRAC. 
Since this project aims to solely describe the panorama of AF 
ablation in Brazil, with no intention of elucidating the reasons for 
procedure outcomes, no correlations were made between the 
data analyzed. The forms were received between September 22, 
2006, and November 20, 2006. Registry information, therefore, 
based on the preceding 12 months, refers to ablations performed 
between September 2005 and November 2006. This interval will 
henceforth be referred to as the registry period.  
Continuous variables were expressed as means and 
categorical variables as percentages. 
Results
A total of 29 groups from 13 states in five regions of the 
country filled in the questionnaire. A complete list of the 
registry participants may be found in the appendix. Most (n = 
16; 55%) were from the Southeast region (6 from São Paulo, 4 
from Rio de Janeiro, 4 from Minas Gerais, and 2 from Espírito 
Santo), 5 groups (17%) were from the Northeast (Bahia, Ceará, 
Pernambuco, Piauí, and Rio Grande do Norte), 4 (14%) were 
from the South region (2 from Paraná and 2 from Rio Grande do 
Sul), 3 (10%) were from the Central-West (all from the Federal 
District), and one (4%) was from the North (Pará). All these 
groups are distinctly representative of their regions and regularly 
carry out ablation procedures, but only 22/29 (76%) of these 
teams mentioned performing curative AF ablation. The report 
of these 22 groups comprised the basis of the registry.
Curative AF ablation in Brazil began in 1998: between 
this year and 2001, 7 groups (32%) started to perform these 
procedures, and another 15 groups (68%) began ablations 
between 2002 and 2006. From 1998 to 2006, a total of 2,374 
patients were submitted to AF ablation, 755 (32%) of them 
during the registry period (the previous 12 months). As to the 
experience of the groups, the number of patients submitted to 
AF ablation during the registry period (n = 755) varied from 1 
to 125. During this period, 8 groups (36%) carried out between 
one and 10 cases, totalizing 36 patients (5%); 4 groups (18%), 
reported between 11 and 20 cases, totalizing 53 patients (7%); 
1 group (5%) between 21 and 30 cases, totalizing 26 patients 
(4%); 6 groups (27%) between 31 and 65 cases, totalizing 327 
patients (43%); and only 3 groups (14%) performed more than 
65 cases, totalizing 313 patients (41%).
As is illustrated on Table 1, of the 755 patients submitted 
to ablation in the registry period, most  (70%) were males 
and 89% presented with paroxysmal or persistent AF. As 
to criteria for indication of the procedure, 91% of the 
groups referred that the patients had to be refractory to 
Table 1 - Clinical presentation and criteria used by the groups 
to indicate the procedure
Type of atrial fibrillation (n = 755)
Paroxysmal 436 (58%)
Persistent 235 (31%)
Permanent 84 (11%)
Male patients 528 (70%)
Refractoriness to drugs
1 drug 2 groups (9%)
2 drugs 20 groups (91%)
Minimum left ventricular ejection fraction
Normal 5 groups (23%)
40%-50% 7 groups (32%)
30%-40% 8 groups (36%)
< 30% 2 groups (9%)
Maximum diameter of the left atrium
40 mm-50 mm 8 groups (36%)
50 mm-55 mm 11 groups (50%)
> 55 mm 3 groups (14%)
n - number of patients.
259
Original Article
Fenelon et al
Brazilian Registry of Atrial Fibrillation Ablation
Arq Bras Cardiol 2007; 89(5) : 258-262
two antiarrhythmic drugs  (names of the drugs were not 
given); 55% stated that only patients with normal or slightly 
diminished left ventricular ejection fractions were included; 
and 86% of the groups stated that the diameter of the left 
atrium could be no larger than 55 mm.
The ages of the 755 patients varied between 18 and 85 
years (means were not provided). As to the geriatric population, 
19 groups (86%) carried out ablations in patients over 65 years 
of age; 16 groups (73%), in individuals over 70 years of age; 
10 groups (45%), in those over 75 years of age; and only 3 
groups (14%) admitted patients over 80 years of age.
As to preoperative tests to evaluate the presence of 
intracavitary thrombi and/or anatomy of the left atrium, most 
groups (n = 20; 91%) routinely adopted transesophageal 
echocardiography. Magnetic nuclear resonance was used 
by 12 groups (55%) and only 2 groups (9%) performed 
computed tomography. All of the groups used radiofrequency 
as the source of energy for ablation and only one group also 
used ultrasound. Most groups (n = 17; 77%) used ablation 
catheters with 8 mm tips, 4 groups (18%) used irrigated 
catheters, and only 2 groups (9%) used catheters with 4 mm 
tips. In the postoperative period, all 22 groups (100%) adopted 
anticoagulation with warfarin, 14 (64%) of them for two to 
four months, and the other 8 (36%) for periods greater than 
four months.
As to ablation approaches adopted isolatedly or in 
combination (Table 2), 10 groups (46%) used electrical 
isolation of pulmonary veins guided by fluoroscopy, as 
recommended by Haissaguerre et al3-5; 8 groups (36%) isolated 
the antra of the pulmonary veins guided by intracardiac 
echocardiography, as described by Natale et al6-8; and 3 
groups (14%) performed circumferential ablation of pulmonary 
veins guided by electroanatomic mapping systems as per 
Pappone et al9-11 and Osil et al11 Other approaches such as 
fragmented electrogram ablation, described by Nademanee 
et al12, ablation of AF nests proposed by Pachón et al13, and 
ablation of the parasympathetic ganglia, reported by the 
Oklahoma group14, were used by fewer groups. The ablation 
of the cavotricuspid isthmus was carried out by 13 groups 
(59%), and electrical isolation of the superior cava was done 
by 4 groups (18%). It is noteworthy that 9 groups (41%) 
referred having used auxiliary imaging methods (intracardiac 
echocardiography and electroanatomic mapping) to perform 
the procedure. 
Information on the success of ablation was provided by 18 
groups (82%). During an average five-month follow-up period 
(one to eleven months), the total success of the procedure, 
defined as maintenance of the sinus rhythm, was 82% (66%-
100%). On the other hand, success without the need for 
antiarrhythmic drugs was 57% (17%-100%). In order to obtain 
these results, 65% of the patients required one, 30% required 
two, and 5% required more than two procedures.
A total of 111 complications (14.3%) were reported by 
19 groups (86%), as is shown on Table 3. The most frequent 
Table 2 - Ablation approaches used by the groups
Technique used Number of groups
Electrical isolation of PV by 
fluoroscopy 10 (46%)
Ablation of PV antra with 
intracardiac ECHO 8 (36%)
Circumferential ablation of PV with 
EAM 3 (14%)
Ablation of fragmented potentials 2 (9%)
Ablation of AF nests 2 (9%)
Ganglion ablation 1 (4%)
Use of auxiliary methods (ECHO 
or EAM) 9 (41%)
PV - pulmonary veins; ECHO - echocardiography; EAM - electroanatomic 
mapping; AF - atrial fibrillation.
Table 3 - Number of complications in the 755 patients of the registry
Type of complication Number of complications
Atrioesophageal fistula 1 (0.1%)
Pulmonary vein stenosis/
occlusion 3 (0.4%)
Transient ischemic attack 11 (1.4%)
Cerebrovascular accident 8 (1.0%)
Cardiac tamponade 29 (3.8%)
Pericardial effusion 7 (0.9%)
Phrenic nerve lesion 2 (0.2%)
Post-ablation tachycardia 29 (3.8%)
Hematomas or hemorrhages 18 (2.3%)
Anesthesia accidents 3 (0.4%)
Total 111 (14.3%)
were cardiac tamponade and post-ablation iatrogenic atrial 
tachycardias (n = 29; 3.8%). Eight (1.0%) cerebrovascular 
accidents with sequelae were reported and 11 (1.4%) of them 
were transient. Significant pulmonary vein stenosis (> 50%) 
and/or occlusion were detected in three patients (0.4%), and 
only one (0.1%) atrioesophageal fistula was observed. Two 
(0.26%) deaths were reported which occurred in the first 
30 days (atrioesophageal fistulae) and three months (post-
tamponade sepsis) after the ablation procedure. 
Discussion
This registry was a pioneer initiative of SOBRAC with the 
intention of delineating the profile of curative AF ablation in 
Brazil. This survey shows that, over the last few years, the use 
of these procedures has been increasing in all regions of the 
country. Corroborating this observation, between 2002 and 
2006, there was a marked increase in the number of centers 
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initiating AF ablation programs (n = 15; 68%) compared to 
the early period from 1998 to 2001 (n = 7; 32%). This is also 
attested by the experience with the technique shown by the 
teams: 8 groups (36%) carried out less than 11 cases during the 
year of the registry, suggesting programs under development, 
while only 9 groups (40%) with more than 30 cases in the year 
could be considered experienced. Additionally, 755 (32%) of 
the 2,374 patients submitted to AF ablation between 1998 and 
2006 were included during the registry period, i.e., in the 12 
months prior to answering the questionnaire. Nevertheless, 
among the registry participants, 7 groups (24%) had not yet 
begun AF ablation programs, indicating that there is potential 
for increasing the use of these procedures in our midst. 
Over the last decade, both in other countries and in Brazil, 
the techniques used in curative AF ablation went through 
profound transformations evolving from the elimination of 
ectopic foci inside arrhythmogenic pulmonary veins to total 
electric isolation of these vessels2-11. Furthermore, modern 
approaches also modified the atrial substrate, primarily in 
the posterior wall of the left atrium16. This technological 
progression and its impact on the results of the procedure 
were not analyzed by this registry. Since the proposal was to 
document the present status of AF ablation in Brazil, with no 
biases introduced by obsolete techniques, the registry period 
was essentially restricted to the year 2006. Thus, the results 
of this registry could be directly applied in clinical practice. 
In conformity with the current nature of this registry, the 
techniques most reported by the groups in this investigation, 
i.e., electric isolation of pulmonary vein segments (46%)4, 
intracardiac echocardiographic ablation of pulmonary 
vein antra (36%)8, and electroanatomic mapping-guided 
circumferential ablation of the pulmonary veins (14%)11, are 
also the most commonly used in other countries. Additionally, 
similar to the international situation, recent techniques aiming 
to modify the atrial substrate (ablation of fragmented potentials 
and AF nests)12,13 and autonomous modulators (ablation of 
parasympathetic ganglia)14,15 have also been used in our 
country, although on a smaller scale. 
Despite the short follow-up period (five months) of 
patients in this survey, the data are comparable to those of the 
international survey done by Cappato et al18 In this important 
research project, 90 centers from various countries and with 
different levels of experience provided information on the 
curative AF ablations performed on 8,745 patients between 
1995 and 2002. Comparable to the SOBRAC registry, most 
patients were males (64%) and from a similar age bracket 
(16-86 years). They presented with paroxysmal or persistent 
AF, were refractory to antiarrhythmic drugs, had left atrium 
diameters of up to 55 mm and at least 40% left ventricular 
ejection fraction. These authors reported a 76% total success 
rate and a 52% success rate without antiarrhythmic drugs, 
results very close to those of the SOBRAC study, 82% and 
57%, respectively. The percentages of patients that requiring 
two or more ablation procedures in the international registry 
(24% and 3%) and in the national registry (30% and 5%) were 
also similar, whereas the rate of complications in the SOBRAC 
registry (14.3%) was higher than that of the international registry 
(5.9%). In the latter, however, the post-ablation iatrogenic 
tachycardia cases25 observed in 3.9% of the patients18, the 
occurrence of hematomas, and the anesthesia complications 
were not counted in the general total. In the SOBRAC registry, 
these events answered for 45% of all complications. Despite 
differences in method, both studies showed that AF ablation is 
associated with serious complications such as cerebrovascular 
accidents, cardiac tamponade, pulmonary vein stenosis, and 
atrioesophageal fistulae19. These outcomes were responsible 
for the deaths reported in the national (n = 2; 0.26%) and 
international (n = 4; 0.05%) registries. These aspects indicate 
that AF ablation, as per Brazilian guideline recommendations, 
2 should be performed by experienced groups in centers with 
adequate infrastructure and surgical backup.  Postoperative 
care is also important, especially the use of full anticoagulation 
for several months, a recommendation that was followed by 
all participants of the registry.
In face of the complexity and risks of curative AF ablation, 
several imaging techniques have been developed with the 
purpose of increasing the efficacy and safety of the procedure. 
Among them, the most widely accepted internationally 
are the electroanatomic mapping systems and intracardiac 
echocardiography8,17. The former allow a tridimensional 
reconstruction of the left atrium and pulmonary vein ostium 
besides a precise quantification of the radiofrequency lesion 
application sites, while the latter allows real-time monitoring 
of transseptal punctures, positioning of the catheters in the 
pulmonary vein region, and formation of intracavitary thrombi. 
Data from the national registry demonstrate that these 
techniques have been incorporated into our midst because 
9 groups (41%) reported having used at least one of these 
auxiliary methods during the registry period.
Limitations - The registry is voluntary and reflects the 
experience of the participants and not that of all centers in the 
country. However, the institutions that participated are highly 
representative in their respective regions and at SOBRAC. A 
limitation inherent to the registry is that data are not controlled, 
and verification of information is difficult. Nevertheless, since 
the results and complications reported are similar to those 
found in medical literature18, we believe that the registry 
figures are trustworthy. As was mentioned before, in order to 
assure confidentiality, the rates of success and complications 
were not correlated with the volume of cases from each 
institution. The techniques for AF ablation evolve quickly2,16. 
Therefore, the information collected during the registry period 
(2005-2006) may not entirely mirror current practices. In this 
regard, the registry should be periodically updated. 
Conclusions
The use of curative AF ablation has been increasing 
significantly in our midst and is available in several Brazilian 
states. The success rates reported are comparable to those 
from international registries, but in approximately 40% of the 
patients, an additional procedure is needed. In spite of very 
promising results, AF ablation still leads to significant morbidity. 
Ancillary imaging methods have been used more and more 
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in Brazil with the objective of increasing the efficacy and 
safety of the procedure. These findings should be taken into 
consideration by public and private funding agencies. 
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